abstract |
The present invention relates to compounds of formula (I). The compounds of formula I are modulators of factor XII, especially factor XIIa. These compounds are inhibitors of factor XIIa and may be useful as anticoagulants. The compounds of formula I can be used in a method of treating (or preventing) blood disorders associated with bleeding or coagulation. |